7801 Center Avenue
Huntington Beach, CA 92647
The Image Center | Beverly Hills
450 North Bedford Drive, Suite 200
Beverly Hills, CA 90210
The Velscope Exam
In our continuing efforts to provide the most advanced technology and highest quality care available to our patients, we are proud to announce the inclusion of the Velscope exam as an integral part of our annual comprehensive oral cancer screening program.
During the exam, the Velscope will emit a safe blue light into the oral cavity causing it to flouresce. The clinician is then able to immediately view the different flourescence responses to help differentiate between normal and abnormal tissues. Typically, healthy tissue appears as a bright apple green glow while suspicious regions are identified by a loss of flourescence, which thus appear dark.
Healthy Tissue - No Lesion / Unhealthy Tissue - Dark Area
One person dies every hour from oral cancer in the United States – and the mortality has remained unchanged for more than 40 years. Alarmingly, more than 25% of oral cancer victims have no lifestyle risk factors.
Clinical studies have determined that using Velscope after the standard oral cancer examination improves the clinician’s ability to identify, evaluate and monitor suspicious areas at their earliest stages. Early detection of pre-cancerous tissue can minimize or eliminate the potentially disfiguring effects of oral cancer and possibly save your life.
Proven screening technologies such as mammogram, Pap smear, PSA and colonoscopy offer the same types of early detection of cancer. Velscope is an easy and painless examination that gives this practice the best chance to find any oral abnormalities you may have at the earliest possible stage. This technology is the only FDA-cleared device for the identification and monitoring of oral abnormalities that could lead to cancer.
Oral cancer risk by patient profile is listed below:
Highest Risk: Patients age 40 and older and lifestyle risk factors (tobacco use); patients with a history of oral cancer
High Risk: Patients age 40 and older; tobacco users of any age
Increased Risk: Patients age 18 – 39